Originally posted by Stsmark
View Post
Announcement
Collapse
No announcement yet.
Rmyelinating drug already FDA approved
Collapse
X
-
Yes I have Primary Progressive MS which is focused in my cord. It’s actually not a formal trial since the med is OTC in lower doses. As I mentioned the recommended dose is 4mg x 4 daily. They can then monitor via MRI for changes. I believe it’s been going on for about a year, in my case I have not had any MRI since starting.
Comment
-
Here’s from the UCSF site,
- ReBUILD - A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Crossover Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of an Identified Small Molecule as a Remyelinating Agent in Multiple Sclerosis
Comment
- ReBUILD - A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Crossover Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of an Identified Small Molecule as a Remyelinating Agent in Multiple Sclerosis
-
Originally posted by Mitchitsu View PostWow 16mg / day.
I'm taking about half that on my own.
Maybe I should up the dose.
Comment
-
All forms of MS (RRMS, SPMS, PPMS, etc.) can have lesions in both the cord and the brain. The disease is characterized by an autoimmune response to it's own myelin, which breaks down, is replaced by glial cells, and also leads to axonal damage. The differences in the types is not in the location of the lesions, but in the speed and pattern of myelin and axonal loss.
(KLD)The SCI-Nurses are advanced practice nurses specializing in SCI/D care. They are available to answer questions, provide education, and make suggestions which you should always discuss with your physician/primary health care provider before implementing. Medical diagnosis is not provided, nor do the SCI-Nurses provide nursing or medical care through their responses on the CareCure forums.
Comment
Comment